Target intelligence / Profile preview

Retinal (RAL) (RAL)

Target
RAL
Molecular classification
Retinoid, Chromophore, Visual pigment component, Small molecule cofactor
01

Overview

Retinal is the polyene aldehyde form of Vitamin A and serves as the essential light-sensitive chromophore in all visual pigments (Source: PubChem CID 638015). In the vertebrate eye, 11-cis-retinal is covalently bound to opsin proteins via a Schiff base linkage; upon photon absorption, it isomerizes to all-trans-retinal, initiating the phototransduction cascade (Source: Kiser et al., 2014, Chem Rev). This process is vital for vision, and the regeneration of 11-cis-retinal occurs through the enzymatic visual cycle (Source: NIH, StatPearls). Dysregulation of this cycle leads to the accumulation of toxic byproducts like A2E, which are implicated in Stargardt disease and age-related macular degeneration (Source: Sparrow et al., 2010, J Lipid Res). Therapeutic strategies include visual cycle modulators like Emixustat to reduce metabolic stress or synthetic retinoids like QLT091001 to replace deficient chromophores (Source: ClinicalTrials.gov). Monitoring efficacy often involves fundus autofluorescence to track lipofuscin levels and electroretinography to assess retinal sensitivity (Source: NIH).

Other names
RetinaldehydeVitamin A aldehyde11-cis-retinalAll-trans-retinalRetinene
02

Mechanism of action

Visual cycle modulation to reduce toxic byproduct accumulation or chromophore replacement therapy (Source: Kubota et al., 2014; Koenekoop et al., 2014)

03

Biological functions

PhototransductionVisual cycleLight sensingLigand-mediated receptor activation
04

Disease associations

Stargardt diseaseRetinitis pigmentosaAge-related macular degenerationLeber congenital amaurosis
05

Safety considerations

Delayed dark adaptationNight blindness (nyctalopia)TeratogenicityHepatotoxicity
06

Interacting drugs

Emixustat

3 more in the full profile.

07

Biomarkers

Fundus autofluorescence (FAF)Electroretinography (ERG)Serum retinol-binding protein 4 (RBP4) levels

Beyond the preview

Go deeper on Retinal (RAL) (RAL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinal (RAL) (RAL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call